A deep sternal wound infection (DSWI) can become a severe complication after cardiac surgery, with in-hospital mortality rates reaching up to 35%. Staphylococci, particularly methicillin resistant Staphylococcus aureus (MRSA), play important roles in its etiology. This case report presents a patient who underwent coronary artery bypass surgery, and suffered postoperatively from a DSWI caused by MRSA. The pathogen was susceptible to vancomycin and rifampicin in vitro; however, this therapy was clinically ineffective. Both clinical improvement and MRSA eradication were achieved after surgical debridement of the wound and the intravenous administration of dalbavancin. We decided to administer dalbavancin because of its convenient pharmacological profile. The patient’s tolerance of the antimicrobial was good, the biochemical markers of inflammation returned to the normal ranges, and the microbiological results one week after the dalbavancin administration were negative. A good clinical outcome was achieved with both the surgery and antimicrobial administration. In this case, dalbavancin was more effective in the treatment of the sternal and surrounding tissue infections caused by MRSA, when compared to vancomycin.

There is limited information on the clinical characteristics of critically ill patients infected with SARS-CoV-2 and Klebsiella pneumoniae NDM. The objective of this study was to describe such a group of patients hospitalised in the intensive care unit of a large academic hospital during the third wave of the COVID-19 pandemic in Poland. Between 1 March and 30 June 2021, 103 patients were hospitalised, of whom 23 (22.3%) were positive for K. pneumoniae NDM; 14 (61%) of those patients died. Their hospitalisation time varied between 9 and 47 days. Five of the 23 patients (21.7%) were otherwise healthy. In contrast, the others suffered from cardiovascular problems (11, 47.8%), obesity (6, 26.1%), diabetes (5, 21.7%), neurological problems (4, 17.4%), or kidney disease (1, 4.3%); 4 (17.4%) were heavy smokers, and 1 (4.3%) had a history of alcohol abuse. K. pneumoniae NDM was isolated from urine samples of all patients. In 17 patients (73.9%), it was also isolated from other sources: from the respiratory tract in 10 (43.8%), from the blood in 2 (8.7%), and the central venous catheter was contaminated in 1 case (4.3%). Fourteen of the patients (60.9%) were colonised K. pneumoniae NDM. In four patients (17.4%), bacterial and fungal coinfection occurred. In one case (4.4%), two fungal species, Candida albicans and Candida glabrata, were isolated simultaneously. The most frequently administered antimicrobial agent was colistin (60.9%), followed by meropenem (47.8%), vancomycin (47.8%), ceftriaxone (34.8%), linezolid (30.4%), piperacillin/tazobactam (30.4%), and trimethoprim/sulfamethoxazole (30.4%). Other less-frequently administered agents included amikacin, amoxicillin/clavulanate, tigecycline, ciprofloxacin, fosfomycin, clindamycin, and cloxacillin. Fluconazole was administered in 14 patients (60.7%) and micafungin was administered in 2 (8.7%).

Background/Objectives: Stenotrophomonas maltophilia is a critical opportunistic pathogen, yet its long-term epidemiology remains underrepresented in global surveillance frameworks like WHO GLASS. We aimed to analyze its six-year epidemiological trend in a large Polish tertiary hospital. Methods: A retrospective study (2020–2025) of 399 non-duplicate isolates was conducted. Identification was performed using MALDI-TOF MS, and susceptibility was analyzed according to EUCAST breakpoints. Antibiotic consumption (DDD/100 patient-days) was correlated with isolation trends. Results: Wound/skin (36.8%) and lower respiratory tract (35.8%) samples predominated. A significant rise in respiratory isolates was observed post-2020, coinciding with peak carbapenem consumption in ICU and surgical wards. Ward-level analysis demonstrated that intensive care unit status (β = 68.9, 95% CI 46.1–91.8, p < 0.001) and carbapenem consumption (β = 0.080, 95% CI 0.004–0.156, p = 0.041) were independently associated with S. maltophilia isolation burden after adjustment for ward type (adjusted R² = 0.80). While trimethoprim–sulfamethoxazole remained highly active, levofloxacin susceptibility showed high interannual variability. Conclusions: S. maltophilia is a stable and clinically significant threat in high-intensity hospital environments. Our findings support the inclusion of this pathogen in international AMR monitoring (GLASS) and emphasize strict carbapenem stewardship to curb its emergence.